Fig. 1

A, B Representative images and quantification of the peri-implant capsule thickness in the control and green fluorescent protein-adipose-derived stem cell (GFP-ASC) groups. C, D Immunofluorescence staining showing the serial distribution of GFP-ASCs injected into the peri-implant space from postoperative week 2 to 8. E, F Representative images and quantification of Ki67-positive cells in the control and GFP-ASC groups. G, H Representative images and quantification of PH3-positive cells in the control and GFP-ASC groups. I, J Representative images and quantification of Caspase3-positive areas in the control and GFP-ASC groups. Values are presented as mean ± SD (n = 6). Scale bars = 200 μm (A, C); 100 μm (E, G, I). *p < 0.05, ***p < 0.001 versus control or 2 weeks. ## p < 0.01 versus 4 weeks. DAPI, 4′,6-diamidino-2-phenylindole